BSE Smallcap Surges 20% in April as DIIs Absorb $20B FII Exodus

India’s small-caps just posted their biggest monthly surge in over a decade. The BSE Smallcap index surged 20.1% in April 2026, while the BSE Midcap index soared 14.8%, the sharpest monthly rally for both indices in 12 years, per BSE data. The move was powered by domestic investors absorbing the largest foreign equity exodus in Indian market history, with DIIs deploying approximately ₹1.9 trillion even as FIIs pulled over $20 billion from Indian equities in the first four months of 2026. The Nifty Smallcap 250 gained 17.1% in April, its highest monthly return since the index launched in April 2016, per NSE data, while the broader Nifty gained 7.5%, its best month since December 2023, and the Nifty Midcap 150 advanced 13.2%, its best month since November 2020.

The Last Time This Happened Was May 2014

The historical context matters. In May 2014, the BSE Smallcap index gained 20.4% and the BSE Midcap index gained 15.6%, with the Sensex up 8%, the last comparable move in the segment, per BSE data. That was a post-election euphoria trade. April 2026’s move was structurally different: domestic capital filling a vacuum left by the largest foreign exodus in Indian market history.

$20 Billion Out the Door, and Domestic Money Absorbed All of It

The FII vs. DII battle during this period is the real story of April. Foreign investors pulled more than $20 billion out of Indian equities in the first four months of 2026, surpassing last year’s record annual exit of $18.9 billion, with the bulk of the selling coming after military action on Iran began on February 28, per NSDL data. Financial sector stocks bore the brunt, with outflows of ₹79,981 crore, followed by IT stocks at approximately ₹22,000 crore in withdrawals.

And yet small-caps went up 20%. Domestic institutional investors put in approximately ₹1.9 trillion between February 27 and April 27, effectively absorbing the entire ₹1.7 trillion FII withdrawal and adding a net ₹200 billion on top, per NSDL data. DIIs recorded a historic $15.4 billion in local purchases in March alone, offsetting the highest-ever monthly foreign outflows of $12.7 billion in the same month. Small- and mid-caps were the primary destination; large-caps, where FIIs concentrate their holdings, are still sitting 4% to 4.8% below pre-war levels.

734 Stocks Gained Over 20% — The Breadth Was the Story

What stood out was how wide the move was. The Nifty Smallcap 250 had fallen 10% in March, its worst monthly performance since February 2025, per NSE data, making the April rebound all the sharper. Among 1,262 stocks in the BSE Smallcap index, more than half — 734 stocks — returned over 20% in April alone. Of those, 84 stocks surged over 50%, and 474 rallied between 25% and 50%. HFCL, Ola Electric Mobility, Cohance Lifesciences, Cemindia Projects, Gallantt Ispat, and Welspun Corp emerged as the biggest index contributors, surging between 56% and 71% in April. This wasn’t a handful of outliers pulling up an index. The Nifty Metal index was the top sectoral gainer from the war lows, while the Nifty PSU Bank index fell 11% over the same period, a gap that reflects how differently the FII-heavy large-cap banking sector has fared versus domestically owned small-cap industrials.

Three Reasons This Rally Had Legs

G. Chokkalingam, founder of Equinomics Research, attributes the move to three compounding factors: small-caps had a bad 2025, with the BSE Smallcap index falling approximately 29% from its December 12, 2024, peak of ₹57,827 to its April 7, 2025, low of ₹41,013, per BSE data, making valuations genuinely attractive at the trough; a stalled primary market, where 66% of 2026 IPO listings traded below their issue price and retail IPO applications fell roughly 40% in FY26, pushed retail capital into secondary market stocks; and small- and mid-cap companies were relatively insulated from FII selling and rupee weakness compared to large-caps.

“The small-cap rally in April came after a very sharp correction since 2025, when nearly 66% of small-cap stocks had fallen. That correction brought back investor interest in quality small-cap businesses where growth prospects remained strong despite price fall,” said Feroze Azeez, joint CEO, Anand Rathi Wealth. Azeez also noted that continued foreign selling in large-caps pushed more domestic money towards smaller companies.

Small-cap mutual funds delivered double-digit returns of around 10% through late April, outperforming both mid-cap and large-cap peers, with portfolio disclosures from 16 tracked funds showing well-diversified sector bets and no excessive concentration in any single theme.

Also Read: Small-Cap Stocks Gain Up to 56% in 2 Months as Nifty Slides 4%

Valuations Are the Uncomfortable Truth

The rally has pushed valuations back into contested territory, and analysts are split on what comes next. The BSE SmallCap index trades at a price-to-book ratio of approximately 4.2x, well above its long-term average of 2.7x, while the BSE MidCap 400 sits at 4.3x. Small- and mid-cap stocks now trade at a 40% premium to large-caps, compared to a historical average of about 20%, per Nuvama Wealth Management. For global context, small-cap valuations in emerging markets broadly trade at a P/B of around 2.5x, making India’s segment comparatively expensive. Nuvama has flagged that the consensus 22% annual earnings growth projection for small and midcaps appears unrealistic given current economic conditions, predicting the segment will likely remain in a narrow trading range in the near term.

Not everyone agrees. Feroze Azeez of Anand Rathi Wealth argues the trend can sustain over the rest of the year because valuations still appear reasonable, with the Nifty Smallcap 250 trading approximately 17.4% below its estimated fair value. Vikas Gupta, CEO at OmniScience Capital, takes the opposing view that the index has already moved beyond fair value and could see a correction of up to 30% from current levels. “The Smallcap 250 space appeared undervalued until a month ago, which led to a phase of bargain buying,” Gupta said. The two positions reflect a genuine analyst disagreement, not a consensus, and stock selection rather than index-level calls is where most participants are finding common ground.

Gaurang Shah, head investment strategist at Geojit Investments, expects markets to remain choppy in the months ahead and says stock selection, not index exposure, will be key, a view echoed by Ruchit Jain, vice president at Motilal Oswal Financial Services, who expects the Smallcap 250 to gain a further 5–8% immediately after forming a base around its weekly 200-day exponential moving average.

The Forward Risk: Oil at $114 and the Strait of Hormuz

There is a live macro tail risk above all of this. Brent crude futures closed at $114.01 per barrel on April 30, 2026, briefly touching a wartime high of $126 intraday, up from approximately $70 at the start of the war on February 28, as markets reacted to reports that US President Donald Trump would be briefed on expanded military options in Iran and rejected Tehran’s proposal to reopen the strait. Tensions remain elevated despite a ceasefire holding since early April, as US and Iranian blockades have effectively shut the Strait of Hormuz, cutting off a major share of global oil flows.

Analysts at Kotak Securities warn that a diplomatic breakthrough at Hormuz is not their base case and that the rupee’s meaningful support zone sits at 94.50–94.80 against the dollar. Sustained crude above $100 reignites inflation, squeezes consumer demand, and hits corporate margins, precisely the earnings delivery the rally now needs to justify its valuation premium. Of Nuvama’s recommended entry points, chemicals and auto ancillaries carry the most direct crude exposure; consumer durables and IT names such as Coforge are comparatively insulated from oil price pressure.

What Analysts Are Recommending

Jyotivardhan Jaipuria of Valentis Advisors projects 20–25% compounded small-cap returns over two years versus 16% for large-caps, per Valentis Advisors’ May 2026 outlook, but stresses stock selection over index buying at current P/B levels. CLSA analysts led by Vikash Kumar Jain have noted that while the domestic liquidity backstop remains intact, any durable market rally will ultimately need foreign money to return.

For specific entry points, Nuvama’s value-buy picks sit in consumer durables, chemicals, IT, and auto ancillaries: Coforge, Page Industries, UNO Minda, NMDC, Gravita India, PG Electroplast, Aarti Industries, Max Financial Services, JK Cement, and Crompton Greaves Consumer Electricals. Separately, portfolio data from 16 tracked small-cap mutual funds shows banking names like City Union Bank and Karur Vysya Bank feature prominently alongside healthcare and industrials, these are fund holdings, not analyst buy recommendations, and reflect different mandates and entry prices from the Nuvama list above.

Analyst Views on the Q4 FY26 Earnings Trigger